Condition: Coronary Artery Disease (CAD) · Ischemic Heart Disease · Sponsor: Fundación EPIC
International, Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Coroflex® ISAR NEO coronary stent system to meet EU Medical Device regulation (MDR) requirements in all the CONSECUTIVE patients treated with Coroflex® ISAR NEO coronary stent system sirolimus eluting stent.
This description comes directly from the study's public registry record.
koldobika García San Román, MD, PhD · 0034696704643 · koldobikags@hotmail.com
FUNDACION EPIC · 0034987876135 · iepic@fundacionepic.org
Always discuss trial participation with your own doctor first.
| Centre Hospitalier du Pays d'Aix | Aix-en-Provence, France | Recruiting |
| Centre Hospitalier Ajaccio | Ajaccio, France | Recruiting |
| CH Polyclinique Bordeaux Nord Aquitaine | Bordeaux, France | Recruiting |
| University Hospital Center of Caen | Caen, France | Recruiting |
| Hôpital Albert Schweitzer | Colmar, France | Recruiting |
| Hospitalario Universitario (CHU) de Lille | Lille, France | Recruiting |
| APHP -Hôpital Lariboisière | Paris, France | Recruiting |
| Institut Arnault Tzanck | Saint-Laurent-du-Var, France | Recruiting |
| Hospital Universitario A Coruña | A Coruña, Spain | Recruiting |
| Hospital Universitario de Badajoz | Badajoz, Spain | Recruiting |
| Hospital Universitari Germans Trias I Pujol | Badalona, Spain | Recruiting |
| Hospital Universitario de Cruces | Barakaldo, Spain | Recruiting |
+ 10 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05698732